INTERNATIONAL PATENT: INSTITUT GUSTAVE ROUSSY, UNIVERSITE PARIS-SACLAY, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FILES APPLICATION FOR "USE OF A RADIOMICS-BASED SIGNATURE FOR PREDICTING SURVIVAL AND/OR RESPONSE TO IMMUNOTHERAPY WITH OR WITHOUT PRELIMINARY LIVER FOCAL RADIOTHERAPY IN A SUBJECT WITH METASTATIC CANCER WITH LIVER METASTASIS"

GENEVA, Nov. 10 -- INSTITUT GUSTAVE ROUSSY (39, rue Camille Desmoulins94800 VILLEJUIF), UNIVERSITE PARIS-SACLAY (Batiment BREGUET3 Rue Joliot Curie91190 Gif-sur-Yvette), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101 rue de Tolbiac75013 Paris) filed a patent application (PCT/IB2024/000201) for "USE OF A RADIOMICS-BASED SIGNATURE FOR PREDICTING SURVIVAL AND/OR RESPONSE TO IMMUNOTHERAPY WITH OR WITHOUT PRELIMINARY LIVER FOCAL RADIOTHERAPY IN A SUBJECT WITH METASTATIC CANCER WITH LIVER METASTASIS" on Apr 30, 2024. With publication no. WO/2025/229364, the details related to the patent application was published on Nov 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) syst...